awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34503521-6F075183-BFA7-419B-827B-9E8EF99BD014
Q34503521-6F075183-BFA7-419B-827B-9E8EF99BD014
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34503521-6F075183-BFA7-419B-827B-9E8EF99BD014
Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan
P2860
Q34503521-6F075183-BFA7-419B-827B-9E8EF99BD014
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34503521-6F075183-BFA7-419B-827B-9E8EF99BD014
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61a214d7d18b51490bab79f77a10d697146a0836
P2860
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.